Global Longlife Hospital & Research

21.55
-0.45
(-2.05%)
ann
There are new updates from the company11 hours ago
Viewcross
right
Market Cap
22.63 Cr
EPS
-2.08
PE Ratio
23.51
Dividend Yield
0.00 %
52 Week High
46.44
52 Week Low
22.00
PB Ratio
0.89
Debt to Equity
0.24
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,129.40
#1 1,09,792.59
102.90
5,584.10
18.77
#1 1,058
-17.46
59.65
6,492.05
93,345.72
71.54
#1 19,165.50
14.74
917
49.14
54.11
671.80
50,718.09
61.76
6,931.20
8.99
645
#1 89.49
62.72
1,673.40
34,197.74
42.51
5,093.40
10.96
790
2.66
65.20
1,213.85
32,602.48
64.67
2,759.20
#1 25.09
326
15.71
53.06
622.50
24,908.65
70.52
2,511.20
12.94
336
20.76
61.44
453.35
22,645.42
83.71
3,723.70
22.85
205
-69.22
62.46
1,378.50
13,998.90
56.82
1,334.00
10.76
218
10.06
59.81
5,180.00
11,456.25
#1 27.61
599.90
11.69
58
8.85
42.49
1,536.85
10,076.51
57.85
1,095.50
21.32
177
20.14
46.80
Growth Rate
Revenue Growth
-42.62 %
Net Income Growth
-222.22 %
Cash Flow Change
87.46 %
ROE
-397.18 %
ROCE
-211.62 %
EBITDA Margin (Avg.)
-110.11 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
TTM
Revenue
35
34
33
33
24
14
24
Expenses
28
30
27
25
20
14
19
EBITDA
7
4
6
8
4
-0
4
Operating Profit %
20 %
10 %
17 %
24 %
17 %
-2 %
9 %
Depreciation
2
2
1
1
1
1
1
Interest
2
2
2
1
0
1
0
Profit Before Tax
3
-1
2
6
3
-2
3
Tax
1
-0
-0
2
1
-0
1
Net Profit
1
-1
2
4
2
-2
2
EPS in ₹
1.95
-1.23
2.92
5.11
1.79
-2.08
1.80

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
43
42
37
34
76
42
Fixed Assets
20
19
18
17
17
17
Current Assets
15
16
12
11
34
4
Capital Work in Progress
0
0
0
0
1
0
Investments
0
0
0
0
0
0
Other Assets
23
23
19
17
58
25
Total Liabilities
43
42
37
34
76
42
Current Liabilities
13
13
10
14
8
12
Non Current Liabilities
18
17
13
3
4
4
Total Equity
12
12
14
17
64
26
Reserve & Surplus
5
5
7
10
54
15
Share Capital
7
7
7
7
11
11

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
1
-0
-0
3
-3
Investing Activities
-0
0
0
0
-2
-1
Operating Activities
5
4
7
9
-40
-5
Financing Activities
-5
-3
-7
-10
46
3

Share Holding

% Holding
Apr 2021
Nov 2021
Apr 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
0.00 %
81.43 %
54.29 %
54.29 %
54.29 %
54.29 %
54.29 %
54.29 %
54.29 %
54.29 %
54.29 %
54.29 %
54.29 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
35.80 %
39.25 %
39.25 %
39.10 %
35.43 %
35.51 %
36.27 %
37.13 %
34.62 %
31.90 %
31.79 %
Others
100.00 %
18.57 %
9.91 %
6.47 %
6.47 %
6.61 %
10.29 %
10.20 %
9.45 %
8.58 %
11.10 %
13.81 %
13.92 %
No of Share Holders
0
7
1,595
1,011
948
936
888
880
935
947
1,010
974
989

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Closure of Trading Window11 hours ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2025
Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review ReportOct 28, 2024
Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review ReportOct 28, 2024
Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review ReportOct 28, 2024
Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30, 2024 And Other MattersOct 22, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 19, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementOct 03, 2024
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressOct 01, 2024
Board Meeting Outcome for Shifting Of Registered Office Of The Company Within The Local Limit Of CityOct 01, 2024
Closure of Trading WindowSep 30, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 29, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementSep 27, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Reg. 34 (1) Annual Report.Sep 03, 2024
Notice Of The 13Th Annual General Meeting Of The Company.Sep 03, 2024
Corporate Action - Fixes Book Closure For (13Th Annual General Meeting)Aug 30, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2024
Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of 13Th AGM And Other Matters.Aug 30, 2024
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011Aug 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 18, 2024
Financial Results For The Half Year And Year Ended March 31, 2024May 20, 2024
Board Meeting Outcome for Audited Financial Results For The Half Year And Year Ended March 31, 2024May 20, 2024
Voting Results For EGM Held On 14Th May, 2024 In PDF Format.May 16, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMMay 14, 2024
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Along With The Audit Report For The Half Year And Year Ended On March 31, 2024May 12, 2024
Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (LODR) Regulations, 2015Apr 29, 2024
Notice Of EGM To Be Held On Tuesday, 14Th May, 2024Apr 19, 2024
Compliance Certificate For The Year Ended 31.03.2024 As Required Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Apr 19, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 17, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 17, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th April, 2024Apr 12, 2024
Closure of Trading WindowMar 29, 2024
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMar 21, 2024
Board Meeting Outcome for Appointment Of Statutory AuditorMar 21, 2024
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsMar 09, 2024
Intimation Regarding Business Operations Of The CompanyJan 31, 2024
Clarification On Significant Movement In The Price Of Our Security On BSE LimitedJan 05, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jan 05, 2024
Clarification sought from Global Longlife Hospital and Research LtdJan 04, 2024
Unaudited Financial Results For The Half Year Ended On September 30, 2023Nov 11, 2023
Board Meeting Outcome for For Unaudited Financial Results For The Half Year Ended On September 30, 2023Nov 11, 2023
Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30, 2023Nov 04, 2023
Appointment of Company Secretary and Compliance OfficerNov 01, 2023

Technical Indicators

RSI(14)
Neutral
34.68
ATR(14)
Less Volatile
1.41
STOCH(9,6)
Neutral
37.62
STOCH RSI(14)
Neutral
32.33
MACD(12,26)
Bullish
0.07
ADX(14)
Strong Trend
36.59
UO(9)
Bearish
48.66
ROC(12)
Downtrend And Accelerating
-13.21
WillR(14)
Oversold
-98.53